A

Agenus

Organization

Heard in 1 episode across 1 show since Jul 2026

Agenus Inc. is a biotechnology company focused on immunotherapy, including immuno-oncology, which utilizes the immune system to treat cancer. The company develops checkpoint modulators, patient-specific anti-cancer vaccines, and vaccine adjuvants.

Episodes

1
across 1 show

First heard

Jul 2026

Expert statements

1
1 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20261
Aug 20260
Sep 20260
Oct 20260

What experts have said about Agenus

1 statement · 1 positive

  1. Alexis ChristophorousPositiveJul 13, 2026· Stock Movers

    Agenus will use financing proceeds for colon-cancer treatment research and extend cash through 2031.

    “Proceeds going to go toward finding a treatment for colon cancer and extend its cash Runway through the end of 2031.”

    Listen at 2:40

    Open the episode · MGM and Diller; SK Hynix Lower; Agenus Jump

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

1 episode featuring Agenus, newest first